A model for reduced HIV-1 viral load monitoring in resource-limited settings

Journal of the International Association of Providers of AIDS Care
Leeann BryantPhilip Keiser

Abstract

Viral load monitoring of antiretroviral therapy in low-income countries is rarely used because of high costs. Reducing the frequency of monitoring may make it financially feasible. We modeled three testing schemes: reduced viral load monitoring (RVLM) with CD4 count at baseline and viral load testing at 6, 36, and 60 months; United States Department of Health and Human Services (US DHHS) Treatment Guidelines; and World Health Organization (WHO) Guidelines using a cohort of 313 HIV-infected patients using Kaplan-Meier analysis. Median time to detection of antiretroviral therapy (ART) failure using RVLM was 147 days; using US DHHS, it was 115 days; and using WHO guidelines, it was 1110 days. Median time for the development of first thymidine analog mutation was 594 days. The cost of RVLM was significantly lower than US DHHS. RVLM detected failure significantly sooner than CD4 count monitoring alone at a lower cost than US DHHS monitoring. RVLM is a potentially effective method of monitoring ART in resource-limited settings.

References

Dec 8, 2005·Journal of Clinical Microbiology·Cheryl JenningsJames W Bremer
Sep 28, 2006·JAMA : the Journal of the American Medical Association·Benigno RodríguezMichael M Lederman
Nov 1, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Matthew Bidwell GoetzWilliam A O'Brien
Dec 5, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alexandra CalmyWilliam Rodriguez
Dec 5, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shashwatee BagchiMichael S Saag
Aug 19, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Moses R KamyaUNKNOWN Academic Alliance for AIDS Care and Prevention in Africa
Jan 15, 2008·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Laura WatersMark Nelson
Aug 1, 2008·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Denis M TebitHans-Georg Kräusslich
Oct 2, 2008·HIV Medicine·B G GazzardUNKNOWN BHIVA Treatment Guidelines Writing Group
Oct 9, 2009·Journal of the International AIDS Society·David Gilden, Rodney Kort
Apr 21, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·April D KimmelUNKNOWN CEPAC-International Investigators

❮ Previous
Next ❯

Citations

Feb 20, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ellen C CanigliaUNKNOWN Center for AIDS Research Network of Integrated Clinical Systems and the HIV-CAUSAL Collaboration
Jan 1, 2016·Health Promotion International·Sean Slavin
Feb 6, 2020·Journal of Managed Care & Specialty Pharmacy·Thomas WardAlan Oglesby

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked
ELISA

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

The Veterinary Clinics of North America. Food Animal Practice
Anne L Ridler, David M West
ED Management : the Monthly Update on Emergency Department Management
© 2021 Meta ULC. All rights reserved